Recent reports have revived interest in the active role that beta-cells may play in type 1 diabetes pathogenesis at different stages of disease. In some studies, investigators suggested an initiating role and proposed that type 1 diabetes may be primarily a disease of beta-cells and only secondarily a disease of autoimmunity. This scenario is possible and invites the search for environmental triggers damaging beta-cells. Another major contribution of beta-cells may be to amplify autoimmune vulnerability and to eventually drive it into an intrinsic, self-detrimental state that turns the T cell-mediated homicide into a beta-cell suicide. On the other hand, protective mechanisms are also mounted by beta-cells and may provide novel therapeutic targets to combine immunomodulatory and beta-cell protective agents. This integrated view of autoimmunity as a disease of T-cell/beta-cell cross talk will ultimately advance our understanding of type 1 diabetes pathogenesis and improve our chances of preventing or reversing disease progression.
展开▼
